The John A. Spitzer Conference
There are several different options

• Insights from physicians that highlight clinical needs and how devices can address those needs
• New MEMS and sensor technologies that can be utilized for healthcare applications
• Commercialization assessment of new medical products that utilize MEMS sensors
• Strategies for managing regulatory requirements, intellectual property, reimbursement,
Mand adoption


In the coming years biomedical research will accelerate at a rate far exceeding the rates of the past few decades. People will start to be individually distinguished with great accuracy through personal requirements as it relates to medications, devices, the environment in which they live, and other factors. This personal treatment will become possible because of the technology being developed that will enable huge data sets on large populations to be analyzed.

This conference will bring together experts to discuss the medicine of the future and the key enablers of new medical products. The integration of MEMS sensors will be accelerated by recently-developed infrastructure, such as wireless connectivity, multi-functional systems on a chip, data analytics, and creative packaging.  A clinical perspective will be presented identifying actual needs which will subsequently drive the concepts for new products. Connecting the end-user view with the possibilities presented by new technologies will provide the insights needed to overcome the barriers commonly associated with launching disruptive medical products.

Health and Fitness – Perspective on Wellness
New MEMS technologies and integration strategies have brought forward numerous opportunities for products previously not possible to realize. Inertial sensing, energy harvesting, wireless communication, software fusion, and data management are integration platforms that allow MEMS and sensors to be used in new ways for health and fitness consumer products. Some of these devices can have applications that are more clinical such as physiological monitoring, diagnostics, and therapeutics. This session will discuss the current MEMS sensor technologies, their current product applications, how they relate to new clinical opportunities, and the biggest challenges that need to be addressed with the emerging opportunities.

Home Health Care – Extended Patient Care
Home health care is a rapidly growing market being bolstered by products utilizing low cost MEMS sensors. There are obvious advantages of self-monitoring such as reducing medication and emergency room visits. Despite knowing this, other challenges continue to exist - such as ease of use, cost suitability for reimbursement, accuracy and reliability, and management of patient compliance. In this session, potential solutions to these challenges will be discussed including new roles for the patient as well as opportunities for new MEMS sensors and data management strategies.

Metabolic Syndrome – Advancements in Disease Management
Over the past few years biomedical sensor technology has been on a development trajectory (advanced form, function, and cost) that has made “personal wearable” health applications nearly a $2 billion market in 2013. Beyond, “fun and fitness” advanced sensor capabilities are enabling clinicians the opportunity to explore new facets of patient care. For instance, the growing understanding of the individual differences in metabolic phenotypes brought about by nutrigenomics and metabolomic profiling emphasizes the importance of a targeted approach to metabolic derangement manifesting as insulin resistance, dyslipidemia, hypertension, and obesity. The advances in sensor technology and metabolic analyzers complement the direction towards defining each individual’s metabolic signature, the analysis of which can refine fitness management. Given the multifactorial nature of obesity, the main contributor to maintaining the disease, despite all weight loss measures taken, is easily masked. Being able to isolate this specific factor, through sensor technology, can significantly improve outcomes per individual via distinct dietary and behavioral modifications, like time of exercise or sleep patterns.

Sensors for Hospitals - Improvement for Patient Care
The use of sensors, actuators and wireless technologies is transforming the modern hospital as well as the detection and treatment of disease in other clinical settings. MEMS and Sensor technologies are providing opportunities to reduce large, bulky equipment with portable machines, to facilitate faster diagnostic tests providing quicker feedback to clinicians while improving accuracy of results, and to enable new surgical techniques leading to improved patient care and saved lives. With this rapid pace of technological change, many challenges arise in integrating these new technologies into the work flow of the hos-18pxpital, clinicians, nursing and ancillary staff and other human factors issues. This session will focus on the impact of new technologies on doctors, nurses, and patients. This session will focus on the impact of new technologies on physician and nurse workflows and decision-making, as well as on patients. Our goal is to provide insights relative to exciting new and developing technologies likely to impact the detection of disease and the delivery of care.

Matt Apanius

Companies that design, develop and manufacture sensor based medical products
Companies that design, develop and manufacture nanotechnology for medical applications
Healthcare professionals who have an interest within their organization (hospital, etc.)
to keep up with new technologies
Individuals and companies who want to learn more about the technology evolution
in health care
Foundries and OSATs that want to understand more about regulatory guidelines
for manufacturing
MEMS technologists who want to hear about the clinician’s perspective of new products


MICHAEL F. ROIZEN, M.D., has founded or cofounded 12 companies and four of the seven that have reached conclusions have been successfully sold. He is currently Chief Wellness Officer and Chair of the Wellness Institute at Cleveland Clinic. He is a Phi Beta Kappa graduate of Williams College and Alpha Omega Alpha graduate of the University of California, San Francisco, School of Medicine. He performed his residency in internal medicine at Harvard’s Beth Israel Hospital and completed Public Health Service at the National Institutes of Health in the laboratory of Irv Kopin and Nobel Prize winner Julius Axelrod.